GPRIN1 was found to be significantly high in patients with lymph node metastasis (Figure 5E), while FCRL5 was low expressed in patients with the clinical stage (Figure 5F), lymph node metastasis (Figure 5G), and distant metastasis (Figure 5H). Here, FCRL5 is linked to metastatic malignant neoplasm in the lymph nodes.